Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy.
about
Neoantigen-based cancer immunotherapyBiomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and othersPositive intratumoral chemokine (C-C motif) receptor 8 expression predicts high recurrence risk of post-operation clear-cell renal cell carcinoma patientsImmune DNA signature of T-cell infiltration in breast tumor exomes.Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies.HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.Profiling networks of distinct immune-cells in tumors.TIminer: NGS data mining pipeline for cancer immunology and immunotherapy.Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profilesGenomic Correlates of Immune-Cell Infiltrates in Colorectal CarcinomaDiversity and divergence of the glioma-infiltrating T-cell receptor repertoire.Biomarker in Colorectal Cancer.Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.Immunotherapy biomarkers 2016: overcoming the barriers.Systematic evaluation of immune regulation and modulationThe colorectal cancer immune microenvironment and approach to immunotherapies.Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells.Genomic and transcriptomic heterogeneity of colorectal tumors arising in Lynch Syndrome.Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.Immune classifications with cytotoxic CD8+ and Th17 infiltrates are predictors of clinical prognosis in glioblastoma.Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma.Gene expression markers of Tumor Infiltrating Leukocytes.Immune checkpoints and their inhibition in cancer and infectious diseases.High-throughput genomic profiling of tumor-infiltrating leukocytes.Computational genomics tools for dissecting tumour-immune cell interactions.Immunoregulatory functions of VISTA.Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment.Gene-expression profiling to predict responsiveness to immunotherapy.Applications of Immunogenomics to Cancer.Genomic Instability in Cancer: Teetering on the Limit of Tolerance.The colorectal cancer immune paradox revisited.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis.Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women.Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer.Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer.
P2860
Q26738693-CDEDA72E-C338-44D7-B017-E1972C3F9B6BQ28072468-010CF677-3139-48C9-A806-7493C13FCE53Q28602010-93FE6B28-31F2-4C76-85B8-99D24A6E863AQ30377226-AA68C915-A6C3-4E3C-AE2C-07D9E83E7CDDQ33722799-F15A9B63-569D-4EB1-8F63-924AA781E4F4Q35828467-CA9BDE3A-23A7-4F81-961F-26DF817D78DFQ35860201-9C0C7181-9147-4948-A7ED-D3FBBEE452EEQ36067826-73D637F1-496C-4241-AE66-9D9C3C15DE24Q36410615-9AB21B5A-2F0A-401D-945F-12BD5C41B577Q36499105-1D0B76E3-84D2-4A1A-A8FC-3C6255C8FA68Q36850230-EC7E7F8F-35CE-403D-B0F5-CFB716D9FB68Q37040756-12AAF97C-09E8-43EC-8B8D-8AAF41575ECDQ37114675-C8EF5A27-1B3F-4F12-9DB5-BF0EBB482622Q37193493-57FE249A-7C57-44E0-91EB-C8C23BAE539CQ37642614-FA0E237C-67A4-42A6-9A77-401E41EC859FQ37713438-3998328F-8384-4780-AF80-D281D91A8BF1Q37713498-1046D1E3-D99B-4F5F-8BAF-552274564CEDQ38638847-03563A58-AFAB-4545-9EBB-099B780D83D1Q38647855-3FF9FF59-E09A-4BEE-A54F-01F0D8DE43BFQ38670418-8E7ED4B1-F2D5-4EDE-B96F-96A6680AF0E9Q38688789-E70458CC-2679-4024-803D-1AD0FCC93CCDQ38691992-551604A2-7A7A-461A-BF89-2CD6DFCEB4C6Q38726535-7DD7569C-86C5-4EDC-AA66-E93308FBAA10Q38751460-97CBA808-16FE-4F5C-A985-3DE870EFCD8DQ38752940-BFF3A2AD-5CFC-48DB-8DF0-DDEE818739F7Q38845026-26B5C0D1-2543-411E-B651-D6A755EA777AQ38884388-18233960-0473-465F-BDDB-F9A302C0B3E4Q38885361-B01AB0A0-2977-4012-9674-2A6B82466B33Q38930123-E9E71286-FD27-417E-900B-3014969E1D72Q38996594-8ED4FC44-AF08-47D0-989F-7970F7285E4FQ39005203-0AC5E009-B368-4138-81AB-AFC0E62EE729Q39130420-B1112DBC-B02F-436F-9D3E-7E8557CB0A85Q39255507-AE6E0EA7-B89F-4FF8-BCE7-E1ABD630D863Q39280831-699BA317-699C-4F65-A9D9-DA59F2688BBBQ39313889-1BA50F9B-25D9-488A-A723-92F9CA629B5DQ39930421-D76A67A0-ADBD-4CD7-8B18-FD68337DE65EQ39970530-9E1BC653-E400-465B-B5F2-46F5E71716A7Q40423175-19614140-727F-477B-A172-C480532F849FQ40469741-05632F5D-252E-4975-8BF3-B3169F3C7948Q41047932-AE631A83-51C2-4EA6-B4FB-E0D535918598
P2860
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Characterization of the immuno ...... vel targets for immunotherapy.
@ast
Characterization of the immuno ...... vel targets for immunotherapy.
@en
type
label
Characterization of the immuno ...... vel targets for immunotherapy.
@ast
Characterization of the immuno ...... vel targets for immunotherapy.
@en
prefLabel
Characterization of the immuno ...... vel targets for immunotherapy.
@ast
Characterization of the immuno ...... vel targets for immunotherapy.
@en
P2093
P2860
P50
P1433
P1476
Characterization of the immuno ...... ovel targets for immunotherapy
@en
P2093
Anne M Krogsdam
Bernhard Mlecnik
Gabriela Bindea
Maria L Fischer
Pornpimol Charoentong
Zlatko Trajanoski
P2860
P2888
P356
10.1186/S13059-015-0620-6
P577
2015-03-31T00:00:00Z
P5875
P6179
1037738332